KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinomaNan Chen, Li Zhang|Cancer Immunology Immunotherapy|2017Cited by 292
Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancerSheng Jin, Li Zhang|Scientific Reports|2016Cited by 201
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingJørn Herrstedt, Florian Scotté, Maria-Angeles Garcia-del-Barrio et al.|ESMO Open|2024Cited by 141
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survivalWenfeng Fang, Li Zhang|Oncotarget|2015Cited by 93
MNX1 Is Oncogenically Upregulated in African-American Prostate CancerLi Zhang, Michael Ittmann, Jianghua Wang et al.|Cancer Research|2016Cited by 66